Immutep
IMMP
$2.48
Share price
-1.20%
Change (1 day)
52.15%
Change (1 year)
Categories
Earnings for Immutep (IMMP)
Earnings in 2017 (TTM): -$9.21 M
According to Immutep's latest financial reports the company's current earnings (TTM) are -$9.21 M. In 2023 the company made an earning of -$26.42 M a decrease over its 2022 earnings that were of -$22.17 M.The earnings displayed on this page is the company's Pretax Income.
Earnings history for Immutep from 2008 to 2017
Annual earnings
| Year | Earnings | Change |
|---|---|---|
| 2023 | -$26.42 M | 19.17% |
| 2022 | -$22.17 M | -1.36% |
| 2021 | -$22.47 M | 142.76% |
| 2020 | -$9.26 M | -28.16% |
| 2019 | -$12.89 M | 36.64% |
| 2018 | -$9.43 M | 21.42% |
| 2017 | -$7.77 M | -83.55% |
| 2016 | -$47.21 M | 90.52% |
| 2015 | -$24.78 M | 97.4% |
| 2014 | -$12.56 M | -9.17% |
| 2013 | -$13.83 M | -32.31% |
| 2012 | -$20.42 M | -9.42% |
| 2011 | -$22.55 M | 49.18% |
| 2010 | -$15.12 M | 536.13% |
| 2009 | -$2.38 M | 31.37% |
| 2008 | -$1.81 M |
Earnings for similar companies or competitors
| Company | Earnings | Earnings differencediff. | Country |
|---|---|---|---|
 Illumina ILMN | -$1.04 B | 11,199.55% | 🇺🇸 USA |
 FibroGen FGEN | -$0.29 B | 3,016.79% | 🇺🇸 USA |
 HTG Molecular Diagnostics
HTGM | -$19.53 M | 112.13% | 🇺🇸 USA |